SciSparc Ltd. Company Profile
NASDAQ: SPRCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
SciSparc at a glance
SciSparc Ltd. (NASDAQ: SPRC) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Tel Aviv-Yafo, Israel. SciSparc is led by Mr. Oz Adler C.P.A. and employs about 3 people. At a market capitalization of $2.6 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001611746, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does SciSparc do?
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and palmitoylethanolamide oral tablets CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- SciSparc Ltd.
- Ticker
- NASDAQ: SPRC
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Oz Adler C.P.A.
- Employees
- 3
- Headquarters
- Tower A, Tel Aviv-Yafo, Israel
- Phone
- 972 7 334 47180
- Website
- scisparc.com
- Market cap
- $2.57M
- SEC CIK
- 0001611746
Companies similar to SciSparc
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ELABPMGC Holdings Inc. | 3.13 | -2.04% | $2.53M | vs SPRC |
| MTNBMatinas Biopharma Holdings Inc. | 2.83 | +2.17% | $2.77M | vs SPRC |
| PPBTPurple Biotech Ltd. ADR | 1.44 | -1.37% | $2.34M | vs SPRC |
| TCRTAlaunos Therapeutics Inc. | 0.781 | -6.70% | $2.29M | vs SPRC |
| GNPXGenprex Inc. | 2.75 | +4.96% | $2.25M | vs SPRC |
| GOVXGeoVax Labs Inc. | 0.2866 | -0.97% | $2.90M | vs SPRC |
| SILOSilo Pharma Inc. | 1.45 | +0.69% | $2.98M | vs SPRC |
| PRFXPRF Technologies Ltd. | 0.8587 | -2.16% | $3.00M | vs SPRC |